LINDSAY SAMARIN: Open Payments
NPI 1467931980 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,596 in 82 payments from 17 companies in 2025. Trend: 2023 $691 · 2024 $1,872 · 2025 $1,596
Food & beverage: $1,596
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $337 |
| GlaxoSmithKline, LLC. | 19 | $259 |
| AstraZeneca Pharmaceuticals LP | 12 | $225 |
| Regeneron Healthcare Solutions, Inc. | 10 | $170 |
| United Therapeutics Corporation | 4 | $120 |
| Amgen Inc. | 4 | $78 |
| Actelion Pharmaceuticals US, Inc. | 3 | $76 |
| Baxter Healthcare | 4 | $74 |
| Insmed, Inc. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $41 |
Products named: DUPIXENT, NUCALA, Tyvaso, TRELEGY ELLIPTA, TEZSPIRE, OPSUMIT, Hillrom - Vest System Model 105 Home Care, BREZTRI.
Industry payments across TN — which companies pay providers there.
